These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 691928

  • 1. [Treatment of essential hypertension with pindolol].
    Kocemba J, Kawecka-Jaszcz K, Sniezek M, Starzycka M, Augustyński W.
    Kardiol Pol; 1978; 21(3):201-8. PubMed ID: 691928
    [No Abstract] [Full Text] [Related]

  • 2. [A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
    Marinković M, Winter-Fudurić, Kuzmanić D.
    Lijec Vjesn; 1976 Apr; 98(4):172-6. PubMed ID: 787710
    [No Abstract] [Full Text] [Related]

  • 3. Haemodynamic effects of pindolol in essential hypertension with special reference to resistance vessels in the forearm during maximal vasodilatation.
    Gretzer I, Dunér H, Lagerbäck B.
    J Hypertens Suppl; 1985 Dec; 3(3):S215-7. PubMed ID: 2856707
    [Abstract] [Full Text] [Related]

  • 4. [Prolonged antihypertensive effect of beta-adrenolytic treatment with Visken in patients with essential hypertension].
    Lukasik S, Halawa B, Surowiak M, Kasprzak J.
    Pol Tyg Lek; 1977 Nov 21; 32(47):1837-9. PubMed ID: 341096
    [No Abstract] [Full Text] [Related]

  • 5. [Haemodynamic effect of short-term adrenergic block with prindolol at rest and during strain in hypertonic subjects (stage II)].
    Ressl J, Chrástek J, Jandová R, Nhon TQ.
    Cas Lek Cesk; 1974 Oct 25; 113(43):1317-21. PubMed ID: 4429976
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of visken and hypothiazide on the indices of the central and renal hemodynamics in patients with atherosclerotic hypertension].
    Shishkina OS.
    Vrach Delo; 1990 Apr 25; (4):41-3. PubMed ID: 2275163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of essential hypertension with prindolol].
    Kuska J, Sledzinski Z, Kokot F.
    Wiad Lek; 1977 Apr 01; 30(7):505-10. PubMed ID: 855327
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of the treatment with propranolol and pindolol on selected hemodynamic parameters in patients with primary arterial hypertension].
    Trojnar R, Markiewicz M, Rymar B, Wysokiński A.
    Wiad Lek; 1977 Apr 01; 42(16-18):929-34. PubMed ID: 2701039
    [Abstract] [Full Text] [Related]

  • 10. [Long-term treatment of essential hypertension using a beta-receptor blockader: effect on total-body-potassium and exchangeable sodium].
    Brecht HM, Werner E, Vlachoyannis J, Bechstein PB, Schoeppe W.
    Verh Dtsch Ges Inn Med; 1976 Apr 01; 82 Pt 2():1329-32. PubMed ID: 1029992
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel, Gyntelberg F.
    Ugeskr Laeger; 1973 May 17; 135(20):971-4. PubMed ID: 4585570
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL, Vasiuk IuA, Romashkin AV, Sivkov SI, Mel'nikov AIu, Buskin VD.
    Sov Med; 1990 May 17; (3):64-7. PubMed ID: 2195673
    [No Abstract] [Full Text] [Related]

  • 17. [Pindolol in benign essential hypertension. A group study by 12 Zürich internists].
    Rhomberg F, Bächtold H, Danczkay I, Hugentobler F, Jaccard G, Kälin R, Pugatsch I, Stauffenegger M, Veraguth F, Waldvogel W.
    Schweiz Med Wochenschr; 1979 Jun 30; 109(26):990-4. PubMed ID: 462166
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of pindolol on blood parathyroid hormone concentration.
    Shasha SM, Ben Aryeh H, Shiller M, Bernheim J.
    Isr J Med Sci; 1981 Dec 30; 17(12):1189-90. PubMed ID: 7327921
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.